Having trouble accessing articles? Reset your cache.

New listings push IPO pace ahead of last year’s

Five new listings on NASDAQ suggest persistent appetite for biotech IPOs

A spate of biotech IPOs this week in which five companies raised nearly $620 million helped push the biopharma sector’s total haul from NASDAQ listings ahead of 2018’s record pace.

Of the five to price this week, four companies were biopharmas. In that category, 24 companies have raised more than $2.4 billion via NASDAQ

Read the full 535 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE